T99	ZeroArticleNP 72 80	solution
T100	IndefiniteNP 140 172	a sterile, nonpyrogenic solution
T101	DefiniteNP 397 409	the presence
T102	ZeroArticleNP 572 580	products
T103	DefiniteNP 673 691	the administration
T104	ZeroArticleNP 629 663	monoamine oxidase (MAO) inhibitors
T105	ZeroArticleNP 765 782	Drug Interactions
T106	IndefiniteNP 913 922	a sulfite
T107	DefiniteNP 1080 1102	The overall prevalence
T108	DefiniteNP 1129 1151	the general population
T109	IndefiniteNP 1336 1365	any alkaline diluent solution
T110	ZeroArticleNP 1413 1430	alkaline solution
T111	DefiniteNP 1498 1521	the same administration
T112	DefiniteNP 1593 1623	The intravenous administration
T113	ZeroArticleNP 1627 1636	solutions
T114	ZeroArticleNP 1802 1826	potassium-free solutions
T115	DefiniteNP 2363 2380	the effectiveness
T116	DefiniteNP 2397 2410	the incidence
T117	DemonstrativeNP 2323 2339	These conditions
T118	DefiniteNP 2620 2628	the dose
T119	IndefiniteNP 2570 2589	an increased number
T120	DefiniteNP 2717 2739	the diastolic pressure
T121	DefiniteNP 2766 2784	the pulse pressure
T122	DefiniteNP 2844 2861	the infusion rate
T123	DefiniteNP 2886 2897	the patient
T124	IndefiniteNP 2690 2713	a disproportionate rise
T125	IndefiniteNP 2991 3000	an effect
T126	DefiniteNP 3075 3092	the infusion rate
T127	ZeroArticleNP 3030 3050	lower infusion rates
T128	IndefiniteNP 3229 3264	a more potent vasoconstrictor agent
T129	DefiniteNP 3593 3601	the skin
T130	DefiniteNP 3605 3620	the extremities
T131	IndefiniteNP 3355 3364	a history
T132	IndefiniteNP 3554 3565	any changes
T133	DefiniteNP 3691 3701	the result
T134	DefiniteNP 3732 3747	the extremities
T135	DefiniteNP 3749 3761	the benefits
T136	DefiniteNP 3833 3841	the risk
T137	IndefiniteNP 3625 3633	a change
T138	ZeroArticleNP 3765 3806	continued dopamine hydrochloride infusion
T139	DefiniteNP 3916 3924	the rate
T140	DefiniteNP 3942 3954	the infusion
T141	DemonstrativeNP 3864 3878	This condition
T142	DefiniteNP 4091 4106	the possibility
T143	DefiniteNP 4148 4165	the infusion site
T144	IndefiniteNP 4049 4061	a large vein
T145	DefiniteNP 4252 4273	the antecubital fossa
T146	DefiniteNP 4300 4310	the dorsum
T147	DefiniteNP 4314 4322	the hand
T148	DefiniteNP 4385 4396	the patient
T149	ZeroArticleNP 4338 4361	suitable infusion sites
T150	DefiniteNP 4439 4452	The physician
T151	DefiniteNP 4514 4531	The infusion site
T152	DefiniteNP 4679 4687	the area
T153	IndefiniteNP 4827 4840	an adrenergic
T154	ZeroArticleNP 4850 4855	agent
T155	DefiniteNP 4916 4928	the solution
T156	DefiniteNP 4962 4979	the ischemic area
T157	IndefiniteNP 4857 4866	A syringe
T158	IndefiniteNP 4872 4896	a fine hypodermic needle
T159	DefiniteNP 5080 5088	the area
T160	DefiniteNP 5187 5204	the extravasation
T161	PersonalPronoun 5258 5260	it
T162	DefiniteNP 5244 5256	the infusion
T163	DefiniteNP 5300 5308	the dose
T164	DefiniteNP 5477 5498	the following indices
T165	DefiniteNP 5607 5615	the case
T166	IndefiniteNP 5619 5639	any adrenergic agent
T167	ZeroArticleNP 5556 5587	dopamine hydrochloride infusion
T168	ZeroArticleNP 5789 5797	solution
T169	DefiniteNP 5937 5950	the container
T170	IndefiniteNP 5863 5879	a pumping device
T171	DefiniteNP 6214 6227	the condition
T172	DefiniteNP 6231 6251	the patient warrants
T173	ZeroArticleNP 6173 6201	prolonged parenteral therapy
T174	DefiniteNP 6399 6413	the myocardium
T175	DefiniteNP 6417 6427	the action
T176	DefiniteNP 6571 6613	the beta-adrenergic stimulating properties
T177	DemonstrativeNP 6500 6516	This interaction
T178	DemonstrativeNP 6617 6637	these catecholamines
T179	DefiniteNP 7081 7091	the effect
T180	DemonstrativeNP 7044 7055	this enzyme
T181	DefiniteNP 7191 7209	the administration
T182	DefiniteNP 7313 7327	the usual dose
T183	ZeroArticleNP 7141 7155	MAO inhibitors
T184	IndefiniteNP 7413 7424	an additive
T185	ZeroArticleNP 7385 7400	diuretic agents
T186	DefiniteNP 7505 7531	the cardiovascular effects
T187	ZeroArticleNP 7535 7552	adrenergic agents
T188	ZeroArticleNP 7602 7633	beta-adrenergic blocking agents
T189	DefiniteNP 7671 7702	The peripheral vasoconstriction
T190	ZeroArticleNP 7758 7790	alpha-adrenergic blocking agents
T191	ZeroArticleNP 7882 7913	beta-adrenergic blocking agents
T192	DefiniteNP 7985 8035	the dopaminergic renal and mesenteric vasodilation
T193	ZeroArticleNP 8049 8075	low-dose dopamine infusion
T194	DefiniteNP 8078 8097	The concomitant use
T195	IndefiniteNP 8163 8182	some oxytocic drugs
T196	ZeroArticleNP 8115 8137	vasoconstrictor agents
T197	PersonalPronoun 8340 8342	It
T198	ZeroArticleNP 8447 8469	anticonvulsant therapy
T199	IndefiniteNP 8625 8656	a suitable intravenous catheter
T200	DefiniteNP 8750 8758	the rate
T201	IndefiniteNP 8668 8686	An IV drip chamber
T202	IndefiniteNP 8690 8720	other suitable metering device
T203	DefiniteNP 8830 8853	the desired hemodynamic
T204	DistributiveNP 8784 8796	Each patient
T205	DefiniteNP 8921 8941	the desired increase
T206	DefiniteNP 8970 8993	the optimum dosage rate
T207	DefiniteNP 9075 9100	the hemodynamic condition
T208	IndefiniteNP 9049 9060	a reduction
T209	DefiniteNP 9377 9390	the flow rate
T210	IndefiniteNP 9315 9343	a more concentrated solution
T211	IndefiniteNP 9394 9422	a less concentrated solution
T212	ZeroArticleNP 9425 9439	Drug additives
T1	Drug_Class 629 663	monoamine oxidase (MAO) inhibitors
T2	Drug 695 717	dopamine hydrochloride
T4	Drug 1372 1394	dopamine hydrochloride
T5	Substance 1413 1430	alkaline solution
T7	Drug 5556 5587	dopamine hydrochloride infusion
T8	Drug_Class 5642 5671	Solutions containing dextrose
T12	Drug 6289 6301	Cyclopropane
T13	Drug_Class 6305 6340	halogenated hydrocarbon anesthetics
T14	Drug_Class 6439 6480	intravenously administered catecholamines
T15	Drug 6490 6498	dopamine
T18	Drug 6746 6758	dopamine HCl
T19	Drug 6781 6793	cyclopropane
T20	Drug_Class 6797 6832	halogenated hydrocarbon anesthetics
T21	Drug_Class 7005 7028;7030 7040	monoamine oxidase (MAO) inhibition
T22	Drug 7095 7103	dopamine
T25	Drug 7359 7380	low-dose dopamine HCl
T26	Drug_Class 7385 7400	diuretic agents
T29	Drug_Class 7464 7489	Tricyclic antidepressants
T30	Drug_Class 7535 7552	adrenergic agents
T33	Drug_Class 7602 7633	beta-adrenergic blocking agents
T34	Drug 7574 7582	dopamine
T35	Drug 7643 7654	propranolol
T36	Drug 7659 7669	metoprolol
T38	Drug 7727 7739	dopamine HCl
T39	Drug_Class 7758 7790	alpha-adrenergic blocking agents
T40	Drug_Class 7916 7930	Butyrophenones
T41	Drug 7940 7951	haloperidol
T42	Drug_Class 7957 7971	phenothiazines
T43	Drug 8058 8075	dopamine infusion
T47	Drug_Class 8101 8113	vasopressors
T48	Drug_Class 8115 8137	vasoconstrictor agents
T49	Drug 8147 8157	ergonovine
T50	Drug_Class 8168 8182	oxytocic drugs
T51	Drug 8237 8246	phenytoin
T52	Drug 8269 8281	dopamine HCl
T56	Drug 8413 8422	phenytoin
T57	Drug 8383 8395	dopamine HCl
T58	Drug_Class 7882 7913	beta-adrenergic blocking agents
T59	Drug_Class 472 501	Solutions containing dextrose
T60	Drug_Class 1433 1462	Solutions containing dextrose
T61	Drug 2527 2539	dopamine HCl
T62	Drug 3189 3201	dopamine HCl
T63	Drug 5312 5324	dopamine HCl
T64	Drug_Class 7141 7155	MAO inhibitors
T65	Drug 0 22	DOPAMINE HYDROCHLORIDE
T66	Drug 37 59	dopamine hydrochloride
T67	Drug 83 136	Dopamine Hydrochloride and 5% Dextrose Injection, USP
T68	Drug 176 198	Dopamine Hydrochloride
T69	Drug 266 288	Dopamine hydrochloride
T70	Drug 344 366	Dopamine hydrochloride
T71	Drug 1279 1301	Dopamine Hydrochloride
T72	Drug 1919 1941	dopamine hydrochloride
T73	Drug 2018 2040	dopamine hydrochloride
T74	Drug 2820 2842	dopamine hydrochloride
T75	Drug 3775 3806	dopamine hydrochloride infusion
T76	Drug 3972 4025	Dopamine Hydrochloride and 5% Dextrose Injection, USP
T77	Drug 7254 7276	dopamine hydrochloride
T78	Drug 8533 8555	Dopamine Hydrochloride
T79	Drug 8881 8903	dopamine hydrochloride
T80	Drug 9135 9157	dopamine hydrochloride
T81	Drug 9462 9484	Dopamine Hydrochloride
T82	Drug_Class 5623 5639	adrenergic agent
T83	Drug 4916 4928	the solution
T84	Drug 6956 6967	propranolol
T85	Drug 3273 3287	norepinephrine
T86	Drug 2433 2441	dopamine
T87	Drug 6878 6886	dopamine
T88	Drug 6978 6986	dopamine
T89	Drug 7213 7221	dopamine
T90	Drug 7792 7800	Dopamine
T91	Substance 1802 1811	potassium
T92	Drug_Class 8447 8461	anticonvulsant
T6	Substance 895 911	sodium bisulfite
T17	Drug 4750 4825	0.9% Sodium Chloride Injection, USP containing from 5 to 10 mg phentolamine
R9	PredicateNominative Attribute:T100 Head:T67
R10	Anaphora Anaphor:T140 Antecedent:T138
R11	Anaphora Anaphor:T155 Antecedent:T154
R12	Anaphora Anaphor:T162 Antecedent:T83
R13	Anaphora Anaphor:T180 Antecedent:T88
